Delaware regulator flags carriers potentially stretching step therapy exceptions to biologics

Story Summary
By Carleen Bongat Delaware's insurance regulator is warning carriers they may be overstepping on how they apply step therapy exceptions to biologics. On March 24, 2026, the Delaware Department of Insurance issued Domestic and Foreign Insurers Bulletin No. 165, signed by Commissioner Trinidad Navarro and directed at all insurers, health service corporations,.





